Reviewing Clinical Development Strategies for Treg Therapies Across Global Studies

2:00 pm - Wednesday 24th March 2027

  • Examining the rationale for advancing complementary Treg clinical programs across multiple geographies and indications
  • Evaluating early clinical observations from sorted Treg therapies in graft-versus-host disease and other immune-mediated settings
  • Determining how emerging clinical data can guide future development priorities and broader application of Treg therapies

Speakers:

Founding Scientist & Chief Scientific Officer
Regatta Bio